Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Crinetics Pharmaceuticals (CRNX) has a market cap of $2.76 billion USD. According to our data, Crinetics Pharmaceuticals is ranked No.3479 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $2.76 B |
-41.80%
|
| Dec 31, 2024 | $4.74 B |
43.70%
|
| Dec 29, 2023 | $3.30 B |
94.43%
|
| Dec 30, 2022 | $1.70 B |
-35.59%
|
| Dec 31, 2021 | $2.63 B |
101.35%
|
| Dec 31, 2020 | $1.31 B |
-43.76%
|
| Dec 31, 2019 | $2.33 B |
-16.34%
|
| Dec 31, 2018 | $2.78 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
| Market Cap | = | CRNX Stock Price | * | CRNX Shares Outstanding |
| = | $29.66 | * | 93.05 M | |
| = | $2.76 B |